These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1243205)

  • 41. [Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations].
    Fuks A; Carballal G; Manni JA
    Medicina (B Aires); 1979; 39(3):289-97. PubMed ID: 514050
    [No Abstract]   [Full Text] [Related]  

  • 42. Relationship of phytohaemagglutinin-induced lymphocyte transformation to disease activity in systemic lupus erythematosus.
    Hughes P; Holt S; Rowell NR; Dodd JK
    Ann Rheum Dis; 1976 Apr; 35(2):97-105. PubMed ID: 1085134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
    Sølling J; Sølling K; Jacobsen KU
    Acta Derm Venereol; 1979; 59(5):421-6. PubMed ID: 93365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
    Brooks WH; Netsky MG; Normansell DE; Horwitz DA
    J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.
    Suciu-Foca N; Buda JA; Thiem T; Reemtsma K
    Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phytohemagglutinin (PHA) skin test. Characterization of immunological properties and clinical application.
    Nishido T
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):43-55. PubMed ID: 371848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effects of bilirubin on cellular immune responses in man.
    Rola-Plezczynski M; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1975 May; 86(5):690-6. PubMed ID: 124327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.
    Ma H; Wan S; Xia CQ
    J Leukoc Biol; 2016 Jun; 99(6):1121-9. PubMed ID: 26657791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological effects of retinoids.
    Gergely P; Csáky L; González-Cabello P
    Tokai J Exp Clin Med; 1990 May; 15(2-3):235-9. PubMed ID: 1718057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.
    Boelens PG; Fonk JC; Houdijk AP; Scheper RJ; Haarman HJ; Meijer S; Van Leeuwen PA; von Blomberg-van der Flier BM
    Clin Exp Immunol; 2004 May; 136(2):356-64. PubMed ID: 15086402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An immunotoxicological evaluation of gamma-chlordane.
    Johnson KW; Holsapple MP; Munson AE
    Fundam Appl Toxicol; 1986 Feb; 6(2):317-26. PubMed ID: 3486141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of N-nitrosodimethylamine on cell-mediated immunity.
    Holsapple MP; Bick PH; Duke SS
    J Leukoc Biol; 1985 Apr; 37(4):367-81. PubMed ID: 3156199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of cellular mediated immunity in marihuana smokers.
    Nahas GG; Suciu-Foca N; Armand JP; Morishima A
    Science; 1974 Feb; 183(4123):419-20. PubMed ID: 4271816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The immune response of patients with visceral lupus erythematosus treated with corticosteroids (author's transl)].
    Horvat Z
    Lijec Vjesn; 1976; 98(10):523-7. PubMed ID: 1018580
    [No Abstract]   [Full Text] [Related]  

  • 57. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
    Sagawa A; Abdou NI
    J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of famotidine on various immunological parameters in patients with rheumatic diseases: decreased lymphocyte DR expression by famotidine.
    Matsukawa Y; Sawada S; Horie T
    Immunopharmacol Immunotoxicol; 1992; 14(3):477-89. PubMed ID: 1517532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The immunosuppressive mechanism of azathioprine. I. In vitro effect on lymphocyte function in the baboon.
    Brown TE; Ahmed A; Filo RS; Knudsen RC; Sell KW
    Transplantation; 1976 Jan; 21(1):27-35. PubMed ID: 128857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses.
    Balow JE; Parrillo JE; Fauci AS
    Immunology; 1977 Jun; 32(6):899-904. PubMed ID: 328385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.